Concentration-dependent alpha1-Adrenoceptor Antagonism and Inhibition of Neurogenic Smooth Muscle Contraction by Mirabegron in the Human Prostate
Introduction: Mirabegron is available for treatment of storage symptoms in overactive bladder, which may be improved by β3-adrenoceptor-induced bladder smooth muscle relaxation. In addition to storage symptoms, lower urinary tract symptoms in men include obstructive symptoms attributed to benign pro...
Main Authors: | Ru Huang, Yuhan Liu, Anna Ciotkowska, Alexander Tamalunas, Raphaela Waidelich, Frank Strittmatter, Christian G. Stief, Martin Hennenberg |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-06-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2021.666047/full |
Similar Items
-
Inhibition of growth and contraction in human prostate stromal cells by silencing of NUAK1 and -2, and by the presumed NUAK inhibitors HTH01-015 and WZ4003
by: Yuhan Liu, et al.
Published: (2023-04-01) -
Inhibition of α<sub>1</sub>-Adrenergic, Non-Adrenergic and Neurogenic Human Prostate Smooth Muscle Contraction and of Stromal Cell Growth by the Isoflavones Genistein and Daidzein
by: Ru Huang, et al.
Published: (2022-11-01) -
Palliative Radiotherapy and Hormonal Deprivation for Prostate Cancer Induced Urinary Obstruction at a Sub-Saharan Tertiary Hospital
by: Sam Kaggwa, et al.
Published: (2016-11-01) -
Soluble Guanylate Cyclase Activators to Treat Benign Prostatic Hyperplasia and associated LUTS
by: A.J. Kanai, et al.
Published: (2023-06-01) -
Efficacy of holmium laser enucleation of the prostate (HoLEP) in men with bladder outlet obstruction (BOO) and non-neurogenic bladder dysfunction
by: Jong Hyun Pyun, et al.
Published: (2017-09-01)